Dora Zoe Zatyko

Dr. Dora Zoe Zatyko

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2022 in Orvosi Hetilap
Verified
Journal Article
Open access
PDF file
DZDora Zoe Zatyko
Dora Zoe Zatyko
EPEnikő Pomozi
Enikő Pomozi
ÁPÁkos Pataki
Ákos Pataki
ZSZoltán Szeberin
Zoltán Szeberin
Összefoglaló. Bevezetés: Az akut alsó végtagi ischaemia nagy klinikai jelentőségét gyakori előfordulása és súlyos szövődményei (amputáció, halálozás) okozzák. A műtéti megoldás mellett a katéterrel végzett thrombolysis jelent terápiás lehetőséget, használata azonban nem terjedt el széles körben hazánkban. Célkitűzés: A katéterrel végzett thrombolysis hatékonyságának és biztonságosságának megállapítása akut alsó végtagi ischaemia esetén. Módszer: A Semmelweis Egyetem Városmajori Szív- és Érgyógyászati Klinikáján 2012. 03. 01. és 2019. 12. 31. között akut alsó végtagi ischaemia miatt katéteres thrombolysisen átesett 40 beteg (átlagéletkor: 64 év, SD: ±11,79; 25 férfi, 62,5%) adatait elemeztük retrospektív vizsgálat során. Eredmények: 40 páciens esetében 42 katéteres lysist hajtottunk végre. A medián alteplázbolus 5 mg (IQR: 5), a medián folyamatos dózis 2 mg/h (IQR: 0,8) volt. A lysisek közül 23 (54,76%) volt sikeres, ebből 16 (69,57%) esetben végeztünk kiegészítő percutan beavatkozást. Vérzés miatt 5 (11,9%), elzáródás miatt 3 (7,14%) betegen végeztünk sürgős beavatkozást. A leggyakoribb posztoperatív szövődmény az amputáció (17,5%), a haematoma (11,9%) és a distalis embolisatio (7,14%) volt. 16 (40%) esetben végeztünk a lizált érszakaszon később beavatkozást. 11 (27,5%) betegnél történt major amputáció. A posztoperatív 30 napon belüli mortalitás 2,5% volt. Az átlagos beavatkozásmentes időszak 1626 nap (SD: ±1710), az átlagos amputációmentes túlélés 2038 nap (SD: ±1665) volt. A lysis alatt adott intravénás heparin nem befolyásolta a nyitva maradást és az amputációt. Következtetés: A katéterrel végzett thrombolysis terápiás lehetőség akut alsó végtagi ischaemia esetén. Sikeres lysis esetén is gyakran kell endovascularis intervenciót végezni. Katéteres thrombolysis alkalmazásakor számolni kell a gyakori korai szövődmény és a késői reintervenció veszélyével. A pontos terápiás protokoll kialakításához további vizsgálatokra van szükség. Orv Hetil. 2022; 163(11): 424–430. Summary. Introduction: Acute limb ischemia has great clinical significance due to its common occurrence and serious complications. Besides open surgical intervention, catheter-directed thrombolysis is a proven treatment alternative, however, it is not widely used in Hungary. Objective: To evaluate the efficacy and safety of catheter-directed thrombolysis in acute limb ischemia. Methods: In a retrospective single-center study, we analyzed the data of 40 patients (mean age: 64, SD: ±11.79; 25 men, 69.57%) who underwent catheter-directed thrombolysis due to acute limb ischemia at Semmelweis University Heart and Vascular Centre between 01. 03. 2012 and 31. 12. 2019. Results: 42 thrombolysis were performed on 40 patients. The median alteplase dose was 5 mg (IQR: 5), the median continuous dose was 2 mg/h (IQR: 0.8). 23 (54.76%) procedures were successful and 16 (69.57%) cases required further percutaneous interventions. Hemorrhage led to 5 and occlusion to 3 emergency interventions. The most common postoperative complications were amputation (17.5%), hematoma (11.9%) and distal embolisation (7.14%). 16 (40%) cases required late reintervention at the surgical site. 11 (27.5%) cases needed major amputation. 30 day postoperative mortality was 2.5%. Average intervention-free survival was 1626 days (SD: ±1710), while average amputation-free survival was 2038 days (SD: ±1665). Additional intravenous heparin given during thrombolysis did not affect reocclusion rate and amputation-free survival. Conclusion: Catheter-directed thrombolysis is a therapeutic option in acute limb ischemia. Successful thrombolysis often requires endovascular intervention at the same time. Frequent early complications and late reinterventions have to be considered. Further studies are needed for developing specific therapeutic protocol. Orv Hetil. 2022; 163(11): 424–430.

3 August 2026 in JVS-Vascular Insights
Verified
Journal Article
Open access
EAEstela M. Abich
Estela M. Abich
DZDora Zoe Zatyko
Dora Zoe Zatyko
BBBenjamin A Benavides
Benjamin A Benavides
EPEric K. Peden
Eric K. Peden
ALAlan B. Lumsden
Alan B. Lumsden
CBCharudatta S. Bavare
Charudatta S. Bavare

18 August 2026 in Seminars in Vascular Surgery
Verified
Journal Article
Closed access
DZDora Zoe Zatyko
Dora Zoe Zatyko
EAEstela Abich
Estela Abich
ATAnish Tayal
Anish Tayal
ALAlan B. Lumsden
Alan B. Lumsden
CBCharudatta S. Bavare
Charudatta S. Bavare

29 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EPEnikő Pomozi
Enikő Pomozi
DZDora Zoe Zatyko
Dora Zoe Zatyko
FSFerenc Imre Dr. Suhai
Ferenc Imre Dr. Suhai
ZSZoltán Szeberin
Zoltán Szeberin
Background: Lower limb arterial calcification (LLAC) is a robust imaging biomarker of peripheral artery disease (PAD) severity. Vitamin K antagonists are presumed to accelerate cardiovascular calcification. Direct oral anticoagulants (DOACs) may influence vascular calcification differently, but lower limb data are limited. Methods: We performed a single-center retrospective cross-sectional study comparing LLAC on clinically acquired non-contrast CT between DOAC users and controls without anticoagulation. Patients were propensity score-matched 1:1 (48 DOAC vs. 48 control; n = 96) using baseline clinical covariates. Associations between LLAC scores and perioperative or cardiovascular events were assessed. Segment-specific LLAC was quantified on non-contrast CT and normalized for arterial segment length. A prespecified exposure–duration sensitivity analysis compared the outcomes in patients with ≥5 years of continuous DOAC therapy (n = 22) versus matched controls. Results: In the matched cohort, total LLAC scores did not differ significantly between DOAC and control groups (infrarenal aorta: median 7596.0 vs. 8637.0 (p = 0.487), iliac segment: median 5689.5 vs. 5193.5 (p = 0.602). However, in patients with ≥5 years of DOAC use, LLAC scores were significantly lower in proximal segments: infrarenal aorta median 5593.5 vs. 11,185.0 (p = 0.001997) and iliac arteries 5624.5 vs. 11,501.0 (p = 0.001867)). Higher LLAC was associated with major adverse cardiovascular events (such as myocardial infarction, stroke, or significant bleeding) in controls (p = 0.0023) but not in DOAC-treated patients. Conclusions: In this propensity-matched, cross-sectional CT study, long-term DOAC exposure was associated with lower proximal LLAC scores in a small duration-defined subgroup, while the primary matched analysis showed no overall difference in total LLAC scores. Because baseline (pre-DOAC) imaging was unavailable and residual confounding/survivor bias is possible, these findings should be considered hypothesis-generating and require prospective validation. The cohort reflected a mixed lower-extremity vascular population rather than exclusively classic chronic atherosclerotic PAD, which may limit biological interpretation and generalizability.

30 July 2026 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
MVMerlyn Varghese
Merlyn Varghese
ATAnish Tayal
Anish Tayal
MDMadeline Drake
Madeline Drake
PCPonraj Chinnadurai
Ponraj Chinnadurai
DZDora Zoe Zatyko
Dora Zoe Zatyko
ALAlan B. Lumsden
Alan B. Lumsden
A circumaortic renal vein is a congenital vascular anomaly involving an additional renal vein that traverses posterior to the aorta in addition to the normal renal vein traversing anterior to the aorta.1,2 In aortic surgery, it is common to ligate the left renal vein (LRV) to aid in surgical exposure, which is typically inconsequential due to collateral venous channels. We report a case of a circumaortic LRV with the preaortic branch ligated during abdominal aortic aneurysm (AAA) surgery and, as a result, retroaortic LRV hypertrophy was observed during follow-up.

14 July 2026 in Journal of Vascular Surgery Cases, Innovations and Techniques
Verified
Journal Article
Open access
DZDora Zoe Zatyko
Dora Zoe Zatyko
PCPonraj Chinnadurai
Ponraj Chinnadurai
ATAnish Tayal
Anish Tayal
BWBrianna E. Whithorn
Brianna E. Whithorn
ODOrlando M. Diaz
Orlando M. Diaz
ALAlan B. Lumsden
Alan B. Lumsden
Splenic artery aneurysm with arteriovenous fistula is rare and technically challenging, particularly in the setting of marked tortuosity and high-flow shunting. We report the case of a 69-year-old woman treated with a fully endovascular approach guided by intraoperative cone-beam computed tomography. A dual microcatheter technique enabled targeted deployment of detachable coils followed by Onyx embolization, achieving complete fistula occlusion while preserving collateral splenic perfusion through short gastric arteries. The procedure was completed without complications, and the patient was discharged the following day. Advanced endovascular techniques offer a safe and effective alternative for complex visceral vascular pathology.